Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
GDOC vs HRTS
Shared holdings
17
GDOC covered by HRTS
43.02%
HRTS covered by GDOC
43.02%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 40 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
GDOC (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 12.20% | |
| JOHNSON&JOHNSON | 8.10% | |
| ASTRAZENECA PLC | 6.41% | |
| MERCK & CO | 5.99% | |
| BOSTON SCIENTIFIC CORP | 5.81% | |
| THERMO FISHER SCIENTIFIC INC | 4.62% | |
| INTUITIVE SURGICAL INC | 4.47% | |
| GUARDANT HEALTH INC | 3.73% | |
| HOYA CORP | 3.63% | |
| ARGENX SE SPONSORED ADR | 3.60% | |
| CENCORA INC | 3.39% | |
| ABBOTT LABS | 3.13% | |
| LONZA GROUP -REG | 2.94% | |
| AGILENT TECHNOLOGIES INC | 2.91% | |
| DEXCOM INC | 2.68% | |
| ROIVANT SCIENCES LTD | 2.23% | |
| METTLER-TOLEDO INTL INC | 1.77% | |
| APOGEE THERAPEUTICS INC | 1.62% | |
| Sartorius Stedim Biotech S.A. | 1.59% | |
| IONIS PHARMACEUTICALS INC | 1.41% | |
| QIAGEN NV | 1.39% | |
| REPLIGEN CORP | 1.26% | |
| INSMED INC | 1.22% | |
| PENUMBRA INC | 1.14% | |
| Goldman Sachs Treasury Obligations Fund Institutional Class | 1.09% | |
| NATERA INC | 1.05% | |
| XENON PHARMACEUTICALS INC | 1.03% | |
| ROYALTY PHARMA PLC | 1.01% | |
| UNITEDHEALTH GRP | 1.01% | |
| CYTOKINETICS INC | 0.98% | |
| BRIDGEBIO PHARMA INC | 0.92% | |
| MADRIGAL PHARMACEUTICALS INC | 0.89% | |
| RHYTHM PHARMACEUTICALS INC | 0.88% | |
| CG ONCOLOGY INC | 0.83% | |
| ARCELLX INC | 0.82% | |
| GENEDX HOLDINGS CORP-A | 0.59% | |
| REVOLUTION MEDICINES INC | 0.52% | |
| INSULET CORP | 0.47% | |
| ULTRAGENYX PHARMA INC | 0.37% | |
| STRUCTURE THERAPEUTICS INC ADR | 0.30% |
HRTS (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 10.02% | |
| Roche Holding AG | 5.47% | |
| JOHNSON&JOHNSON | 4.86% | |
| ASTRAZENECA PLC | 4.82% | |
| MERCK & CO | 4.24% | |
| THERMO FISHER SCIENTIFIC INC | 3.90% | |
| UNITEDHEALTH GRP | 3.85% | |
| GILEAD SCIENCES INC | 3.62% | |
| Novartis AG (Registered) | 3.62% | |
| ABBOTT LABS | 3.37% | |
| VERTEX PHARMACEUTICALS INC | 3.21% | |
| ABBVIE INC | 2.96% | |
| DANAHER CORP | 2.92% | |
| BOSTON SCIENTIFIC CORP | 2.47% | |
| MEDTRONIC PLC | 2.37% | |
| BRIDGEBIO PHARMA INC | 2.23% | |
| REVOLUTION MEDICINES INC | 2.22% | |
| BRISTOL-MYERS SQUIBB CO | 2.17% | |
| MCKESSON CORP | 2.16% | |
| NOVO NORDISK-B | 2.15% | |
| AMGEN INC | 2.10% | |
| CHUGAI PHARMA CO | 2.06% | |
| REGENERON PHARMACEUTICALS INC | 2.02% | |
| EDWARDS LIFESCIENCES CORP | 1.86% | |
| TEVA PHARMACEUTICAL IND ADR | 1.62% | |
| CYTOKINETICS INC | 1.48% | |
| INTUITIVE SURGICAL INC | 1.47% | |
| MASIMO CORP | 1.36% | |
| DEXCOM INC | 1.29% | |
| MADRIGAL PHARMACEUTICALS INC | 1.21% | |
| INSMED INC | 1.19% | |
| ALNYLAM PHARMACEUTICALS INC | 1.19% | |
| INSULET CORP | 1.04% | |
| ARROWHEAD PHARMACEUTICALS INC | 1.03% | |
| VIKING THERAPEUTICS INC | 0.85% | |
| IONIS PHARMACEUTICALS INC | 0.83% | |
| SCHOLAR ROCK HOLDING CORP | 0.78% | |
| Ascendis Pharma A/S | 0.75% | |
| CRINETICS PHARMACEUTICALS INC | 0.64% | |
| FIRST AM-TR OB-X | 0.59% | |
| NEUROCRINE BIOSCIENCES INC | 0.57% | |
| ZEALAND PHARMA A | 0.56% | |
| GUBRA A/S | 0.51% | |
| INTELLIA THERAPEUTICS INC | 0.35% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.